115 related articles for article (PubMed ID: 31677594)
1. Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Heenkenda MK; Malmström A; Lysiak M; Mudaisi M; Bratthäll C; Milos P; Strandeus M; Åkesson L; Söderkvist P; Uppugunduri S; Osman A
Thromb Res; 2019 Nov; 183():136-142. PubMed ID: 31677594
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Venous Thromboembolism in Patients with Glioblastoma.
Nabi S; Kahlon P; Bozorgnia F; Arshad A; Mikkelsen T; Donthireddy V
Pathol Oncol Res; 2016 Apr; 22(2):311-6. PubMed ID: 26547860
[TBL] [Abstract][Full Text] [Related]
3. ABO Blood Group Is a Predictor for the Development of Venous Thromboembolism After Total Joint Arthroplasty.
Newman JM; Abola MV; Macpherson A; Klika AK; Barsoum WK; Higuera CA
J Arthroplasty; 2017 Sep; 32(9S):S254-S258. PubMed ID: 28366316
[TBL] [Abstract][Full Text] [Related]
4. Recurrent venous thromboembolism in glioblastoma.
Edwin NC; Khoury MN; Sohal D; McCrae KR; Ahluwalia MS; Khorana AA
Thromb Res; 2016 Jan; 137():184-188. PubMed ID: 26657302
[TBL] [Abstract][Full Text] [Related]
5. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J; de la Rocha IV; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M;
Thromb Res; 2015 Dec; 136(6):1199-203. PubMed ID: 26548619
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
8. Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study.
Limperger V; Kenet G; Kiesau B; Köther M; Schmeiser M; Langer F; Juhl D; Shneyder M; Franke A; Klostermeier UK; Mesters R; Rühle F; Stoll M; Steppat D; Kowalski D; Rocke A; Kuta P; Bajorat T; Torge A; Neuner B; Junker R; Nowak-Göttl U
J Thromb Thrombolysis; 2021 Feb; 51(2):494-501. PubMed ID: 32594420
[TBL] [Abstract][Full Text] [Related]
9. Association of blood group and red blood cell transfusion with the incidence of antepartum, peripartum and postpartum venous thromboembolism.
Wang C; Le Ray I; Lee B; Wikman A; Reilly M
Sci Rep; 2019 Sep; 9(1):13535. PubMed ID: 31537816
[TBL] [Abstract][Full Text] [Related]
10. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.
Dentali F; Sironi AP; Ageno W; Turato S; Bonfanti C; Frattini F; Crestani S; Franchini M
Semin Thromb Hemost; 2012 Jul; 38(5):535-48. PubMed ID: 22740183
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.
Streiff MB; Ye X; Kickler TS; Desideri S; Jani J; Fisher J; Grossman SA
J Neurooncol; 2015 Sep; 124(2):299-305. PubMed ID: 26100546
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
13. Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Kapteijn MY; Kaptein FHJ; Stals MAM; Klaase EE; García-Ortiz I; van Eijk R; Ruano D; van Duinen SG; Cannegieter SC; Taphoorn MJB; Dirven L; Koekkoek JAF; Klok FA; Versteeg HH; Buijs JT
Thromb Res; 2023 Jan; 221():10-18. PubMed ID: 36435047
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism (VTE) and glioblastoma.
Yust-Katz S; Mandel JJ; Wu J; Yuan Y; Webre C; Pawar TA; Lhadha HS; Gilbert MR; Armstrong TS
J Neurooncol; 2015 Aug; 124(1):87-94. PubMed ID: 25985958
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
16. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles.
Sartori MT; Della Puppa A; Ballin A; Saggiorato G; Bernardi D; Padoan A; Scienza R; d'Avella D; Cella G
J Neurooncol; 2011 Aug; 104(1):225-31. PubMed ID: 21104297
[TBL] [Abstract][Full Text] [Related]
17. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
[TBL] [Abstract][Full Text] [Related]
18. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma.
Huang Y; Ding H; Luo M; Li S; Xie C; Zhong Y; Li Z
Support Care Cancer; 2022 Jul; 30(7):6063-6069. PubMed ID: 35419733
[TBL] [Abstract][Full Text] [Related]
20. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
Bhanvadia S; Kazerouni K; Bazargani ST; Miranda G; Cai J; Daneshmand S; Djaladat H
World J Urol; 2019 Jan; 37(1):173-179. PubMed ID: 29876671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
